Search references for REPOTRECTINIB. Phrases containing REPOTRECTINIB
See searches and references containing REPOTRECTINIB!REPOTRECTINIB
Medication
Repotrectinib, sold under the brand name Augtyro, is an anti-cancer medication used for the treatment of non-small cell lung cancer. It is taken by mouth
Repotrectinib
Anti-cancer medication
or more prior ROS1 tyrosine kinase inhibitors, including lorlatinib, repotrectinib, and/or taletrectinib. Zidesamtinib was approved for medical use in
Zidesamtinib
American pharmaceutical company
cash, helping to boost its complement of cancer drugs, specifically repotrectinib. That same month, the company announced it would be investing $180m
Bristol_Myers_Squibb
Monoclonal antibody
Infigratinib, Larotrectinib (NTRK), Pemigatinib (FGFR), Pralsetinib, Repotrectinib (ROS1, TRK, ALK), Selpercatinib (VEGFR, FGFR), Taletrectinib (ROS1)
Mosunetuzumab
Medication
Infigratinib, Larotrectinib (NTRK), Pemigatinib (FGFR), Pralsetinib, Repotrectinib (ROS1, TRK, ALK), Selpercatinib (VEGFR, FGFR), Taletrectinib (ROS1)
Elranatamab
Medication
Infigratinib, Larotrectinib (NTRK), Pemigatinib (FGFR), Pralsetinib, Repotrectinib (ROS1, TRK, ALK), Selpercatinib (VEGFR, FGFR), Taletrectinib (ROS1)
Zilurgisertib
Class of pharmaceutical drugs
for treatment of TrkA-, TrkB-, TrkC-, ROS1- and ALK-positive NSCLC) Repotrectinib (TPX-0005, Turning Point Therapeutics) Envonalkib, approved in China
ALK_inhibitor
(INN) Repan reparixin (USAN) Repatha repifermin (INN) repirinast (INN) repotrectinib (INN) repromicin (INN) Repronex reproterol (INN) Requip Resa Resaid
List_of_drugs:_Re
deletions or exon 21 L858R mutations, as detected by an FDA-approved test Repotrectinib Treatment of people aged twelve years of age and older with solid tumors
List of drugs granted breakthrough therapy designation
List_of_drugs_granted_breakthrough_therapy_designation
Pharmaceutical drug classification
L01EX25 Umbralisib L01EX26 Sitravatinib L01EX27 Capivasertib L01EX28 Repotrectinib L01EX29 Vimseltinib QL01EX90 Toceranib L01FA01 Rituximab L01FA02 Ofatumumab
ATC_code_L01
travel, tourism, insurance
REPOTRECTINIB
REPOTRECTINIB
REPOTRECTINIB
REPOTRECTINIB
REPOTRECTINIB
REPOTRECTINIB
REPOTRECTINIB
REPOTRECTINIB
REPOTRECTINIB
travel, tourism, insurance